A critique of D-Wave Quantum Inc. (NYSE:QBTS), amplified by ‘Pharma Bro’ Martin Shkreli, is challenging the company’s viability, alleging its technology is a potential “dead-end.”
Citing multiple research papers, the viral analysis on X makes the shocking claim that it would take D-Wave’s quantum annealer until 2054 to match the current performance of existing classical solvers, raising serious questions about its claimed quantum advantage.
